FMI Unveils Optimistic Future for Optical Coherence Tomography Market, Projections Indicate US$3 Billion Revenue at a 9.8% CAGR

The 2021 global optical coherence tomography market boasted a valuation of US$ 1.1 billion, and it is poised to ascend to US$ 1.2 billion in 2022. Additionally, as the utilization of optical coherence tomography expands across clinical and industrial domains, the market is expected to experience a remarkable compound annual growth rate (CAGR) of 9.8% …

Global Pituitary Stalk Interruption Syndrome Treatment Market is expected to grow at a CAGR of 3.5% During the Forecast Period 2023 to 2033: FMI Study

During the forecast period 2023 to 2033, the pituitary stalk interruption syndrome treatment market is expected to grow at a value of 3.5% CAGR, according to Future Market Insights. By the year 2033, the global market for pituitary stalk interruption syndrome treatment is expected to rise up to a market valuation of US$ 159.14 Million. …

Surgical Advancements Drive Cryotherapy Market Growth, Expected to Reach US$ 14.1 Billion by 2033, According to FMI Analysis

As per the latest analysis report on the cryotherapy market by Future Market Insights, the market is poised for significant growth. With a projected compound annual growth rate (CAGR) of 11.2%, the cryotherapy market is expected to reach a valuation of US$ 4.9 billion by the year 2023, and by 2033, it is forecasted to …

Global Isovaleric Acidemia Treatment Market to reach US$ 1,125.15 Million by 2033; L-Carnitine Supplements based Treatment to comprise 79% of Revenue | FMI

The global isovaleric acidemia treatment market size is expected to be valued at US$ 652.28 Million in 2023 and is projected to reach US$ 1,125.15 Million by 2033, trailing a CAGR of 5.6%. Mass spectrometry development coupled with chromatography has advanced the reliability and efficiency of Isovaleric Acidemia profiling and shows the key structures in …

Helicobacter Pylori Infections Treatment Market to nearly double by 2033, reaching US$ 1,260 Million: FMI Report

The global helicobacter pylori infections treatment market is predicted to reach US$ 638.3 Million in 2023, with a compound annual growth rate (CAGR) of 7.04% anticipated from 2023 to 2033, reaching US$ 1,260 Million. The spread of such infections can be attributed to a number of factors, including a lack of adequate water supply, poor …

Home Healthcare Settings Witness Increased Demand for Patient Monitoring Devices Market to Secure US$ 125.2 Billion Valuation by 2032, According to FMI Analysis

According to Future Market Insights’ most recent market study report on patient monitoring devices market, sales of these products reached US$ 42.3 billion globally in 2021. The market is predicted to reach a valuation of US$ 125.2 billion by 2032 with a CAGR of 10.5% from 2022 to 2032. Blood Glucose Monitoring Systems are anticipated …

Kounis Syndrome Market to Reach US$ 15,990 Million by 2033, Driven by Rising Prevalence of Lifestyle-Associated Disorders | FMI

The global Kounis syndrome market is anticipated to reach a market size of US$ 9098.96 Million in 2023 and US$ 15,990 Million by 2023 to 2033, exhibiting a CAGR of 5.8%. The rising prevalence of chronic diseases like coronary artery disease, ischemic heart disease, and vascular diseases, the rising geriatric population, and the wide range …

Global Ageing Population and Rising Frequency of Chronic Diseases Drive Growth of Barlow’s Syndrome Market at a CAGR of 13% by 2033

The barlow’s syndrome market is anticipated to reach a market size of US$ 181.93 billion in 2023 and US$ 617.57 billion by 2033, at a CAGR of 13%. The global ageing population and rising frequency of chronic diseases are both contributing to the growth of the Barlow’s syndrome market. From 2017 to 2022, the market …

Antibody Therapy Market Set to Disrupt Healthcare: Anticipated Surge to Exceed US$ 824.0 Billion by 2033

The Antibody Therapy Market is expected to grow at a steady CAGR of 13.4% during the forecast period. The market is expected to be worth US$ 824.0 billion by 2033, up from US$ 235 billion in 2023. Higher penetration of adverse diseases like cancer, and COVID-19 spread, has fueled the demand for immunotherapy and antibody …

Growing Prevalence of Ebstein’s Anomaly in Babies to Drive Market Growth Expected to Reach US$ 30 Billion by 2033: FMI Study

During the forecast period 2023-2033, the Ebstein’s anomaly market is expected to grow at a value of 8% CAGR, according to Future Market Insights. The global ebstein’s anomaly market is expected to garner a market value of US$ 13.90 Billion in 2023, By the year 2033, the global market for Ebstein’s anomaly is expected to rise up to a …